These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20228155)

  • 1. Biochemical, cellular, and anti-inflammatory properties of a potent, selective, orally bioavailable benzamide inhibitor of Rho kinase activity.
    Rajagopalan LE; Davies MS; Kahn LE; Kornmeier CM; Shimada H; Steiner TA; Zweifel BS; Wendling JM; Payne MA; Loeffler RF; Case BL; Norton MB; Parikh MD; Nemirovskiy OV; Mourey RJ; Masferrer JL; Misko TP; Kolodziej SA
    J Pharmacol Exp Ther; 2010 Jun; 333(3):707-16. PubMed ID: 20228155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Rho kinase isoforms in lung endothelial cells during inflammation.
    Mong PY; Wang Q
    J Immunol; 2009 Feb; 182(4):2385-94. PubMed ID: 19201893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
    Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
    J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the cytoskeleton in cellular adhesion molecule expression in tumor necrosis factor-stimulated endothelial cells.
    VandenBerg E; Reid MD; Edwards JD; Davis HW
    J Cell Biochem; 2004 Apr; 91(5):926-37. PubMed ID: 15034928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for Rho-kinase in Ca-independent contractions induced by phorbol-12,13-dibutyrate.
    Baek I; Jeon SB; Kim J; Seok YM; Song MJ; Chae SC; Jun JE; Park WH; Kim IK
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):256-61. PubMed ID: 18986333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity.
    Martin MW; Newcomb J; Nunes JJ; Boucher C; Chai L; Epstein LF; Faust T; Flores S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Kim JL; Middleton S; Morgenstern K; Oliveira-dos-Santos A; Patel VF; Powers D; Rose P; Tudor Y; Turci SM; Welcher AA; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Ermann M; Johnston D; Saluste CG
    J Med Chem; 2008 Mar; 51(6):1637-48. PubMed ID: 18278858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets.
    Thienel U; Loike J; Yellin MJ
    Cell Immunol; 1999 Dec; 198(2):87-95. PubMed ID: 10648122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease.
    Stinghen AE; Gonçalves SM; Martines EG; Nakao LS; Riella MC; Aita CA; Pecoits-Filho R
    Nephron Clin Pract; 2009; 111(2):c117-26. PubMed ID: 19147993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chromone analog inhibits TNF-alpha induced expression of cell adhesion molecules on human endothelial cells via blocking NF-kappaB activation.
    Kumar S; Singh BK; Pandey AK; Kumar A; Sharma SK; Raj HG; Prasad AK; Van der Eycken E; Parmar VS; Ghosh B
    Bioorg Med Chem; 2007 Apr; 15(8):2952-62. PubMed ID: 17321745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells.
    Gutjahr MC; Rossy J; Niggli V
    Exp Cell Res; 2005 Aug; 308(2):422-38. PubMed ID: 15950966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors.
    Hopkins AM; Pineda AA; Winfree LM; Brown GT; Laukoetter MG; Nusrat A
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G806-17. PubMed ID: 17138966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity.
    DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Buchanan JL; Buckner WH; Cee VJ; Chai L; Deak HL; Epstein LF; Faust T; Gallant P; Geuns-Meyer SD; Gore A; Gu Y; Henkle B; Hodous BL; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; Masse CE; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; White RD; Zhao H; Zhu L; Zhu X
    J Med Chem; 2006 Sep; 49(19):5671-86. PubMed ID: 16970394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
    Schlüter T; Steinbach AC; Steffen A; Rettig R; Grisk O
    Cardiovasc Res; 2008 Nov; 80(2):271-9. PubMed ID: 18596059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivo.
    LaMontagne KR; Butler J; Borowski VB; Fuentes-Pesquera AR; Blevitt JM; Huang S; Li R; Connolly PJ; Greenberger LM
    Angiogenesis; 2009; 12(3):287-96. PubMed ID: 19544081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGIX-4207 [2-[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenoxy]acetic acid], a novel antioxidant and anti-inflammatory compound: cellular and biochemical characterization of antioxidant activity and inhibition of redox-sensitive inflammatory gene expression.
    Kunsch C; Luchoomun J; Chen XL; Dodd GL; Karu KS; Meng CQ; Marino EM; Olliff LK; Piper JD; Qiu FH; Sikorski JA; Somers PK; Suen KL; Thomas S; Whalen AM; Wasserman MA; Sundell CL
    J Pharmacol Exp Ther; 2005 May; 313(2):492-501. PubMed ID: 15701708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of a novel selective Rho kinase inhibitor, 2-(1H-indazole-5-yl)amino-4-methoxy-6-piperazino triazine (DW1865).
    Oh KS; Oh BK; Park CH; Seo HW; Kang NS; Lee JH; Lee JS; Ho Lee B
    Eur J Pharmacol; 2013 Feb; 702(1-3):218-26. PubMed ID: 23376156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Rho-kinase inhibitors for cardiovascular medicine.
    Shimokawa H; Rashid M
    Trends Pharmacol Sci; 2007 Jun; 28(6):296-302. PubMed ID: 17482681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial Rho and Rho kinase regulate neutrophil migration via endothelial myosin light chain phosphorylation.
    Saito H; Minamiya Y; Saito S; Ogawa J
    J Leukoc Biol; 2002 Oct; 72(4):829-36. PubMed ID: 12377953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.